Flow cytometric T-cell receptor V β repertoire analysis (TCR-V β-R) is a sensitive method to detect T-cell clonality; however, its implementation in low-cellularity specimens has not been established. We developed a strategy to use TCR-V βR in cerebrospinal fluid (CSF) and fine-needle aspirate (FNA) specimens. Initially, full TCR-V β-R was evaluated in diagnostic/ screening specimens from 8 patients with T-cell neoplasia to determine tumor-specific TCR-V β protein expression. Subsequently, an abbreviated, patientspecific TCR-V β-R evaluation was performed in 17 paucicellular specimens from the patients (8 CSF, 9 FNA) for staging and monitoring of minimal residual disease (MRD). A single cocktail containing 3 anti-V β antibodies (1 tumor-specific and 2 negative controls) in combination with other antibodies chosen to help gate on atypical T cells is highly sensitive and specific for detecting low-level neoplastic T-cell involvement in paucicellular specimens. This TCR-V β-R strategy is valuable in staging and evaluating MRD in patients with T-cell non-Hodgkin lymphoma. © American Society for Clinical Pathology.
CITATION STYLE
Tembhare, P., Yuan, C. M., Morris, J. C., Janik, J. E., Filie, A. C., & Stetler-Stevenson, M. (2012). Flow cytometric immunophenotypic assessment of T-cell clonality by V β repertoire analysis in fine-needle aspirates and cerebrospinal fluid. American Journal of Clinical Pathology, 137(2), 220–226. https://doi.org/10.1309/AJCPPT93VZMAREHK
Mendeley helps you to discover research relevant for your work.